Human Activation-Induced Cytidine Deaminase Is Induced by IL-4 and Negatively Regulated by CD45: Implication of CD45 as a Janus Kinase Phosphatase in Antibody Diversification-Reference-Cited by-同舟云学术

Human Activation-Induced Cytidine Deaminase Is Induced by IL-4 and Negatively Regulated by CD45: Implication of CD45 as a Janus Kinase Phosphatase in Antibody Diversification

Published:2003-02-15 Issue:4 Volume:170 Page:1887-1893
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J Immunol

Author:

Zhou Cheng,Saxon Andrew,Zhang Ke

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference59 articles.

1. Specific Expression of Activation-induced Cytidine Deaminase (AID), a Novel Member of the RNA-editing Deaminase Family in Germinal Center B Cells

2. Class Switch Recombination and Hypermutation Require Activation-Induced Cytidine Deaminase (AID), a Potential RNA Editing Enzyme

3. Activation-Induced Cytidine Deaminase (AID) Deficiency Causes the Autosomal Recessive Form of the Hyper-IgM Syndrome (HIGM2)

4. AID is required to initiate Nbs1/γ-H2AX focus formation and mutations at sites of class switching

5. In situ class switching and differentiation to IgA-producing cells in the gut lamina propria

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Th17-inducing dendritic cell vaccines stimulate effective CD4 T cell-dependent antitumor immunity in ovarian cancer that overcomes resistance to immune checkpoint blockade;Journal for ImmunoTherapy of Cancer;2023-11

2. The landscape of T and B lymphocytes interaction and synergistic effects of Th1 and Th2 type response in the involved tissue of IgG4-RD revealed by single cell transcriptome analysis;Journal of Autoimmunity;2022-12

3. Development of Tbet- and CD11c-expressing B cells in a viral infection requires T follicular helper cells outside of germinal centers;Immunity;2022-02

4. AID in Chronic Lymphocytic Leukemia: Induction and Action During Disease Progression;Frontiers in Oncology;2021-05-10

5. Cytidine deamination-induced perpetual immunity to SAR-CoV-2 infection is a potential new therapeutic target;International Journal of Medical Sciences;2021